OtherClinical Investigations (Human)
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
Journal of Nuclear Medicine December 2017, jnumed.117.203257; DOI: https://doi.org/10.2967/jnumed.117.203257
Jeremie Calais
UCLA, United States
Wolfgang P. Fendler
UCLA, United States
Ken Herrmann
UCLA, United States
Matthias Eiber
UCLA, United States
Francesco Ceci
UCLA, United States

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Dec 2017, jnumed.117.203257; DOI: 10.2967/jnumed.117.203257
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
Jeremie Calais, Wolfgang P. Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Dec 2017, jnumed.117.203257; DOI: 10.2967/jnumed.117.203257
Jump to section
Related Articles
Cited By...
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Disparities in PET Imaging for Prostate Cancer at a Tertiary Academic Medical Center
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
- Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists
- One-Step 18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging
- Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
- Molecular Imaging of Prostate Cancer: Choosing the Right Agent
- Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way